| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Raymond James analyst Brian Peterson upgrades Doximity (NYSE:DOCS) from Outperform to Strong Buy and lowers the price target...
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended waiting and not buying Doximity, adding that it is ...
BMO Capital analyst Sean Dodge initiates coverage on Doximity (NYSE:DOCS) with a Market Perform rating and announces Price T...
Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Hold and lowers the price target from $67 to $58.
Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technolog...
Evercore ISI Group analyst Elizabeth Anderson maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target f...
Doximity (NYSE:DOCS) raises FY2026 sales outlook from $628.000 million-$636.000 million to $640.000 million-$646.000 million vs...